1. Search Result
Search Result
Results for "

PCI

" in MedChemExpress (MCE) Product Catalog:

21

Inhibitors & Agonists

1

MCE Kits

1

Inhibitory Antibodies

2

Natural
Products

3

Recombinant Proteins

2

Isotope-Labeled Compounds

2

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-10997
    Ibrutinib
    Maximum Cited Publications
    126 Publications Verification

    PCI-32765

    Btk Ligands for Target Protein for PROTAC Infection Inflammation/Immunology Cancer
    Ibrutinib (PCI-32765) is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM .
    Ibrutinib
  • HY-15224
    PCI-34051
    25+ Cited Publications

    HDAC Apoptosis Cancer
    PCI-34051 is a potent and selective HDAC8 inhibitor with IC50 of 10 nM, with >200-fold selectivity over the other HDAC isoforms.
    PCI-34051
  • HY-10990
    Abexinostat
    5+ Cited Publications

    CRA 024781; PCI-24781

    HDAC Cancer
    Abexinostat (CRA 024781) is a novel pan-HDAC inhibitor mostly targeting HDAC1 with Ki of 7 nM. Abexinostat also inhibits metallo-β-lactamase domain-containing protein 2 (MBLAC2) hydrolase activity with an EC50 below 10 nM .
    Abexinostat
  • HY-16382
    PCI-27483
    1 Publications Verification

    Factor VIIa Cancer
    PCI-27483 is a FVIIa/tissue factor inhibitor, with antitumour effects.
    PCI-27483
  • HY-100335
    PCI-33380
    1 Publications Verification

    Fluorescent Dye Btk Cancer
    PCI-33380 is a fluorescent probe ( (Ex=532 nm, Em=555 nm). PCI-33380 consists of a (BTK) inhibitor PCI-32765 (HY-10997) attaching with a Bodipy-FL fluorophore via a piperazine linker. PCI-33380 binds predominantly to Btk in B cell lysates with cell permeable activity. PCI-33380 can be used for imaging live cancer cells such as non-Hodgkin lymphoma research
    PCI-33380
  • HY-10997A
    Ibrutinib Racemate
    1 Publications Verification

    PCI-32765 Racemate

    Btk Cancer
    Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC50 value of 0.5 nM.
    Ibrutinib Racemate
  • HY-100659

    PCI-45227

    Btk Cancer
    Dihydrodiol-Ibrutinib (PCI-45227) is a dihydrodiol active metabolite of Ibrutinib (HY-10997), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib .
    Dihydrodiol-Ibrutinib
  • HY-10997R

    PCI-32765 (Standard)

    Reference Standards Btk Ligands for Target Protein for PROTAC Cancer
    Ibrutinib (Standard) is the analytical standard of Ibrutinib. This product is intended for research and analytical applications. Ibrutinib (PCI-32765) is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM .
    Ibrutinib (Standard)
  • HY-N3346

    10-epi-Eucarobustol F

    Bacterial Infection
    Macrocarpal A (10-epi-Eucarobustol F) is an antibacterial agent, which can be isolated from the leaves of Eucalyptus macrocarpa. Macrocarpal A inhibits the growth of Bacillus subtilis PCI219 (minimum inhibitory concentration below 0.2 µM) and Staphylococcus aureus FDA209P (minimum inhibitory concentration is 0.4 µM) .
    Macrocarpal A
  • HY-18010
    PCI 29732
    3 Publications Verification

    Btk BCRP Inflammation/Immunology
    PCI 29732 is a potent, orally active, reversible BTK inhibitor with Ki app values of 8.2, 4.6, and 2.5 nM for BTK, Lck and Lyn, respectively. PCI 29732 shows only modest inhibitory activity against Itk, another Tec family kinase. PCI 29732 inhibits the function of ABCG2 by competitively binding to the ATP-binding site of ABCG2 .
    PCI 29732
  • HY-10997S

    PCI-32765-d5

    Btk Cancer
    Ibrutinib-d5 (PCI-32765-d5) is a deuterium labeled Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor .
    Ibrutinib-d5
  • HY-100659S

    PCI-45227-d5

    Btk Isotope-Labeled Compounds Cancer
    Dihydrodiol-Ibrutinib-d5 is the deuterium labeled Dihydrodiol-Ibrutinib (HY-100659). Dihydrodiol-Ibrutinib is a dihydrodiol active metabolite of Ibrutinib (HY-10997), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib .
    Dihydrodiol-Ibrutinib-d5
  • HY-N16374

    Antibiotic Bacterial Fungal Infection Cancer
    Mazethramycin B (Compound II) is an antitumor antibiotic. Mazethramycin B can be isolated from the Streptomyces thioluteusM ME561-L4. Mazethramycin B has a broad-spectrum antimicrobial activity (such as MICs of 1.56 and 6.25 μg/mL for the bacteria Bacillus subtilis PCI 219 and the fungus Candida pseudotropicalis, resepectively). Mazethramycin B significantly increases survival in L1210 leukemia mice model .
    Mazethramycin B
  • HY-16384

    Antibiotic L 156602; PD 124966

    Complement System Inflammation/Immunology
    L-156602 is a C5a receptor antagonist. L-156602 inhibits inflammation, and the migration of monocytes and neutrophils to the infiltrating site in mouse inflammatory models. L-156602 suppresses the efferent phase of delayed-type hypersensitivity (DTH) .
    L-156602
  • HY-10997AR

    PCI-32765 Racemate (Standard)

    Btk Reference Standards Cancer
    Ibrutinib (Racemate) (Standard) is the analytical standard of Ibrutinib (Racemate). This product is intended for research and analytical applications. Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC50 value of 0.5 nM.
    Ibrutinib Racemate (Standard)
  • HY-RS12701

    Small Interfering RNA (siRNA) Others

    SERPINA5 Human Pre-designed siRNA Set A contains three designed siRNAs for SERPINA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    SERPINA5 Human Pre-designed siRNA Set A
    SERPINA5 Human Pre-designed siRNA Set A
  • HY-100335R

    Fluorescent Dye Reference Standards Btk Cancer
    PCI-33380 (Standard) is the analytical standard of PCI-33380 (HY-100335). This product is intended for research and analytical applications. PCI-33380 is a fluorescent probe ( (Ex=532 nm, Em=555 nm). PCI-33380 consists of a (BTK) inhibitor PCI-32765 (HY-10997) attaching with a Bodipy-FL fluorophore via a piperazine linker. PCI-33380 binds predominantly to Btk in B cell lysates with cell permeable activity. PCI-33380 can be used for imaging live cancer cells such as non-Hodgkin lymphoma research
    PCI-33380 (Standard)
  • HY-P992288

    Serpin Inflammation/Immunology
    Anti-PCI Antibody is a monoclonal antibody that targets PCI. Anti-PCI Antibody can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-PCI Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-PCI Antibody
  • HY-RS24688

    Small Interfering RNA (siRNA) Others

    Serpina5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Serpina5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Serpina5 Rat Pre-designed siRNA Set A
    Serpina5 Rat Pre-designed siRNA Set A
  • HY-RS18211

    Small Interfering RNA (siRNA) Others

    Serpina5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Serpina5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Serpina5 Mouse Pre-designed siRNA Set A
    Serpina5 Mouse Pre-designed siRNA Set A
  • HY-182535

    Antibiotic Bacterial Infection
    Tuberactinomycin-O is a peptide antibiotic belonging to the tuberactinomycin family. Tuberactinomycin-O inhibits the growth of various bacteria, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Mycobacterium ATCC 607. Tuberactinomycin-O exhibits acute toxicity in male mice when administered intravenously. Tuberactinomycin-O can be used in the research of tuberculosis .
    Tuberactinomycin-O

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: